In Brief This Week: Eurogentec; NuGen Technologies; Orchid Cellmark | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Eurogentec this week said that its Eurogentec North America subsidiary has received ISO 13485:2003 certification for the production and sale of oligonucleotides for the in vitro diagnostics market. The firm said that it is now the sole custom oligonucleotide contract manufacturing organization to be fully cGMP compliant and have ISO 13485 certified cleanroom sites in North America, Europe, and Asia.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.